Berenberg Research Kicks Off Ypsomed Coverage at Buy

08:32 AM EDT, 10/13/2026 (MT Newswires) -- Berenberg Research on Tuesday began coverage of Swiss medical technology company Ypsomed Holding (YPSN.SW) with a buy rating and price target of 450 Swiss Francs. (MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www.mtnewswires.com/contact-us)